The Beauty Shift
Teoxane commissioned Ipsos to carry out an online opinion poll amongst adults aged 18-25 in the UK, Germany, Italy and Spain.
About the research
The research was conducted by Ipsos on behalf of Teoxane. Ipsos interviewed 2,072 adults aged 18-25 (UK n=514, Germany n=512, Italy n=523, Spain n=523) between 9th February – 26th February 2026.
In each country we achieved c. 500 completes (main sample) and then boosted current/past injectable users to achieve at least 50 in each country. The sample was split by gender, where 70% of women were targeted vs 30% of men. The sample was representative within this split. Amongst this target, we had interlocking quotas on age, region and working status.
The data has been weighted to the known offline population proportions for interlocking cells of gender within age and working status. Data were also weighted to region and education. The boost sample was down weighted to the same proportions as the main sample. Each market was weighted to a sample size of 500 for cross country comparisons.
